{"id":62894,"date":"2026-04-12T11:26:49","date_gmt":"2026-04-12T03:26:49","guid":{"rendered":"https:\/\/flcube.com\/?p=62894"},"modified":"2026-04-12T11:26:50","modified_gmt":"2026-04-12T03:26:50","slug":"norrdia-medical-raises-rmb-100m-to-complete-bellco-acquisition-builds-global-blood-purification-platform","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=62894","title":{"rendered":"NorrDia Medical Raises RMB 100M+ to Complete Bellco Acquisition \u2013 Builds Global Blood Purification Platform"},"content":{"rendered":"\n<p><strong>NorrDia Medical<\/strong>, a Ningbo\u2011based <strong>blood purification specialist<\/strong>, announced completion of a <strong>RMB 100\u202fmillion+ (US$14.6\u202fmillion)<\/strong> financing round to accelerate global expansion and complete strategic asset integration. The round was <strong>led by Zhefu Capital<\/strong>, with participation from <strong>Yongshan Investment Fund<\/strong> and <strong>Ariose Capital<\/strong>.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-transaction-overview\">Transaction Overview<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Component<\/th><th>Detail<\/th><\/tr><\/thead><tbody><tr><td><strong>Amount Raised<\/strong><\/td><td>&gt;RMB 100\u202fmillion (~US$14.6\u202fmillion)<\/td><\/tr><tr><td><strong>Lead Investor<\/strong><\/td><td>Zhefu Capital<\/td><\/tr><tr><td><strong>Co\u2011Investors<\/strong><\/td><td>Yongshan Investment Fund, Ariose Capital<\/td><\/tr><tr><td><strong>Use of Proceeds<\/strong><\/td><td>Bellco asset integration, regulatory registration, domestic\/intl commercial rollout<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-strategic-asset-integration\">Strategic Asset Integration<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Acquisition<\/th><th>Timeline<\/th><th>Assets Acquired<\/th><th>Strategic Value<\/th><\/tr><\/thead><tbody><tr><td><strong>Nikkiso CRRT Business<\/strong><\/td><td>Early\u202f2025<\/td><td>Global continuous renal replacement therapy (CRRT) portfolio; <strong>Aquarius system platform<\/strong>; acute\/critical care blood purification therapies<\/td><td>Entry into acute care segment; established ICU product line<\/td><\/tr><tr><td><strong>Bellco (Medtronic Kidney Care)<\/strong><\/td><td><strong>Pending completion<\/strong><\/td><td>Chronic in\u2011center dialysis portfolio: <strong>dialysis machines, dialyzers, consumables, dialysate fluids<\/strong>; specialty therapies (HFR, PHF, plasma perfusion, inflammatory factor adsorption)<\/td><td>Completes chronic care offering; 20+ country regulatory footprint<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-product-portfolio-amp-regulatory-footprint\">Product Portfolio &amp; Regulatory Footprint<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Acute Care:<\/strong> CRRT systems (Aquarius platform) for ICU\/critical care settings<\/li>\n\n\n\n<li><strong>Chronic Care:<\/strong> Comprehensive in\u2011center dialysis solutions (post\u2011Bellco closing)<\/li>\n\n\n\n<li><strong>Specialty Therapies:<\/strong><\/li>\n\n\n\n<li><strong>HFR<\/strong> (endogenous regeneration hemodiafiltration)<\/li>\n\n\n\n<li><strong>PHF<\/strong> (double\u2011chamber online hemodiafiltration)<\/li>\n\n\n\n<li><strong>Plasma perfusion<\/strong><\/li>\n\n\n\n<li><strong>Inflammatory factor adsorption<\/strong><\/li>\n\n\n\n<li><strong>Global Registrations:<\/strong> EU, China, Canada, Russia, Latin America (<strong>20+ markets<\/strong>)<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-market-context-amp-outlook\">Market Context &amp; Outlook<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Global Dialysis Market:<\/strong> <strong>US$90\u202fbillion+<\/strong> annually; dominated by <strong>Fresenius Medical Care<\/strong> and <strong>Baxter<\/strong>; consolidation creating openings for integrated challengers.<\/li>\n\n\n\n<li><strong>China Opportunity:<\/strong> World&#8217;s <strong>largest ESRD population<\/strong> (~3.5\u202fmillion patients); domestic substitution policies favor local champions with global\u2011quality manufacturing.<\/li>\n\n\n\n<li><strong>Platform Synergy:<\/strong> Combined acute (Nikkiso) + chronic (Bellco) portfolio creates <strong>only China\u2011based competitor<\/strong> with full\u2011spectrum blood purification capabilities across both hospital and outpatient settings.<\/li>\n\n\n\n<li><strong>Revenue Trajectory:<\/strong> Management projects <strong>RMB 500\u202fmillion<\/strong> annual revenue run\u2011rate by 2028 post\u2011integration, driven by China market penetration and emerging market exports.<\/li>\n\n\n\n<li><strong>M&amp;A Pipeline:<\/strong> Additional tuck\u2011in acquisitions targeted in <strong>dialysis services<\/strong> and <strong>peritoneal dialysis<\/strong> segments to complete vertical integration.<\/li>\n<\/ul>\n\n\n\n<p><strong>Forward\u2011Looking Statements<\/strong><br>This brief contains forward\u2011looking statements regarding acquisition completion, regulatory approvals, and commercial projections for NorrDia Medical. Actual results may differ due to risks including integration challenges, regulatory delays, competitive response from incumbents, and foreign exchange volatility.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>NorrDia Medical, a Ningbo\u2011based blood purification specialist, announced completion of a RMB 100\u202fmillion+ (US$14.6\u202fmillion) financing&#8230;<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[7,10],"tags":[4686],"class_list":["post-62894","post","type-post","status-publish","format-standard","hentry","category-company","category-deals","tag-norrdia-medical"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.6 (Yoast SEO v27.3) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>NorrDia Medical Raises RMB 100M+ to Complete Bellco Acquisition \u2013 Builds Global Blood Purification Platform - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"NorrDia Medical, a Ningbo\u2011based blood purification specialist, announced completion of a RMB 100\u202fmillion+ (US$14.6\u202fmillion) financing round to accelerate global expansion and complete strategic asset integration. The round was led by Zhefu Capital, with participation from Yongshan Investment Fund and Ariose Capital.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=62894\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"NorrDia Medical Raises RMB 100M+ to Complete Bellco Acquisition \u2013 Builds Global Blood Purification Platform\" \/>\n<meta property=\"og:description\" content=\"NorrDia Medical, a Ningbo\u2011based blood purification specialist, announced completion of a RMB 100\u202fmillion+ (US$14.6\u202fmillion) financing round to accelerate global expansion and complete strategic asset integration. The round was led by Zhefu Capital, with participation from Yongshan Investment Fund and Ariose Capital.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=62894\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2026-04-12T03:26:49+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-04-12T03:26:50+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1894\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=62894#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=62894\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"NorrDia Medical Raises RMB 100M+ to Complete Bellco Acquisition \u2013 Builds Global Blood Purification Platform\",\"datePublished\":\"2026-04-12T03:26:49+00:00\",\"dateModified\":\"2026-04-12T03:26:50+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=62894\"},\"wordCount\":366,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"keywords\":[\"NorrDia Medical\"],\"articleSection\":[\"Company\",\"Deals\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=62894#respond\"]}],\"copyrightYear\":\"2026\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=62894\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=62894\",\"name\":\"NorrDia Medical Raises RMB 100M+ to Complete Bellco Acquisition \u2013 Builds Global Blood Purification Platform - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"datePublished\":\"2026-04-12T03:26:49+00:00\",\"dateModified\":\"2026-04-12T03:26:50+00:00\",\"description\":\"NorrDia Medical, a Ningbo\u2011based blood purification specialist, announced completion of a RMB 100\u202fmillion+ (US$14.6\u202fmillion) financing round to accelerate global expansion and complete strategic asset integration. The round was led by Zhefu Capital, with participation from Yongshan Investment Fund and Ariose Capital.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=62894#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=62894\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=62894#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"NorrDia Medical Raises RMB 100M+ to Complete Bellco Acquisition \u2013 Builds Global Blood Purification Platform\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"NorrDia Medical Raises RMB 100M+ to Complete Bellco Acquisition \u2013 Builds Global Blood Purification Platform - Insight, China&#039;s Pharmaceutical Industry","description":"NorrDia Medical, a Ningbo\u2011based blood purification specialist, announced completion of a RMB 100\u202fmillion+ (US$14.6\u202fmillion) financing round to accelerate global expansion and complete strategic asset integration. The round was led by Zhefu Capital, with participation from Yongshan Investment Fund and Ariose Capital.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=62894","og_locale":"en_US","og_type":"article","og_title":"NorrDia Medical Raises RMB 100M+ to Complete Bellco Acquisition \u2013 Builds Global Blood Purification Platform","og_description":"NorrDia Medical, a Ningbo\u2011based blood purification specialist, announced completion of a RMB 100\u202fmillion+ (US$14.6\u202fmillion) financing round to accelerate global expansion and complete strategic asset integration. The round was led by Zhefu Capital, with participation from Yongshan Investment Fund and Ariose Capital.","og_url":"https:\/\/flcube.com\/?p=62894","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2026-04-12T03:26:49+00:00","article_modified_time":"2026-04-12T03:26:50+00:00","og_image":[{"width":2560,"height":1894,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","type":"image\/jpeg"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=62894#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=62894"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"NorrDia Medical Raises RMB 100M+ to Complete Bellco Acquisition \u2013 Builds Global Blood Purification Platform","datePublished":"2026-04-12T03:26:49+00:00","dateModified":"2026-04-12T03:26:50+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=62894"},"wordCount":366,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"keywords":["NorrDia Medical"],"articleSection":["Company","Deals"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=62894#respond"]}],"copyrightYear":"2026","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=62894","url":"https:\/\/flcube.com\/?p=62894","name":"NorrDia Medical Raises RMB 100M+ to Complete Bellco Acquisition \u2013 Builds Global Blood Purification Platform - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"datePublished":"2026-04-12T03:26:49+00:00","dateModified":"2026-04-12T03:26:50+00:00","description":"NorrDia Medical, a Ningbo\u2011based blood purification specialist, announced completion of a RMB 100\u202fmillion+ (US$14.6\u202fmillion) financing round to accelerate global expansion and complete strategic asset integration. The round was led by Zhefu Capital, with participation from Yongshan Investment Fund and Ariose Capital.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=62894#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=62894"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=62894#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"NorrDia Medical Raises RMB 100M+ to Complete Bellco Acquisition \u2013 Builds Global Blood Purification Platform"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/62894","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=62894"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/62894\/revisions"}],"predecessor-version":[{"id":62896,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/62894\/revisions\/62896"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=62894"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=62894"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=62894"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}